LEADER 05403nam 2200481 450 001 9910829819503321 005 20231129122506.0 010 $a1-119-82319-6 010 $a1-119-82320-X 035 $a(MiAaPQ)EBC30949526 035 $a(Au-PeEL)EBL30949526 035 $a(EXLCZ)9928861503600041 100 $a20231129d2024 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCancer Consult$hVolume 2. $eExpertise in Clinical Practice /$fedited by Syed A. Abutalib [and three others] 205 $aSecond edition. 210 1$aChichester, England :$cJohn Wiley & Sons Ltd,$d[2024] 210 4$d©2024 215 $a1 online resource (863 pages) 300 $aIncludes index. 311 08$aPrint version: Abutalib, Syed A. Cancer Consult: Expertise in Clinical Practice, Volume 2 Newark : John Wiley & Sons, Incorporated,c2024 9781119823124 327 $aIntro -- Cancer Consult -- Contents -- Editors Volume 2 -- Preface -- Author Bios -- Acknowledgement -- Part 1 Acute Lymphoblastic Leukemia in Adults -- 1 Prognostic Markers and Models in Acute Lymphoblastic Leukemia -- 2 Acute Lymphoblastic Leukemia-Treatment and Outcomes in B-ALL -- 3 T Cell Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma -- 4 Minimal Residual Disease in Acute Lymphoblastic Leukemia -- 5 Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia -- Part 2 Acute Myeloid Leukemia in Adults -- 6 Prognosis in Acute Myeloid Leukemia: Beyond Cytogenetics -- 7 Young Adults with Acute Myeloid Leukemia -- 8 Older Adults with Acute Myeloid Leukemia -- 9 Acute Promyelocytic Leukemia -- 10 Measurable Residual Disease in Acute Myeloid Leukemia -- 11 Hematopoietic Cell Transplantation and Cellular Therapy in Acute Myeloid Leukemia -- Part 3 Myelodysplastic Syndromes and Familial Myeloid Neoplasms -- 12 Diagnosis of Myelodysplastic Syndromes -- 13 Treatment of Myelodysplastic Syndromes -- 14 Hematopoietic Cell Transplantation and Cellular Therapy in Myelodysplastic Syndromes -- 15 Familial Myeloid Neoplasms-When to Suspect and What to Do? -- Part 4 Myeloproliferative Neoplasms -- 16 Chronic Myeloid Leukemia: Chronic Phase Disease -- 17 Chronic Myeloid Leukemia: Advance Phases of the Disease -- 18 Chronic Myeloid Leukemia: Treatment Safety During Reproductive Age and Pregnancy -- 19 Chronic Myeloid Leukemia: Cessation of Therapy -- 20 Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia -- 21 Polycythemia Vera -- 22 Essential Thrombocythemia -- 23 Primary Myelofibrosis -- 24 Hematopoietic Cell Transplantation and Cellular Therapy in Primary and Post ET/PV Myelofibrosis -- 25 Chronic Myelomonocytic Leukemia -- 26 Eosinophilic Myeloproliferative Disorders. 327 $aPart 5 Chronic Lymphocytic and Other Leukemias -- 27 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma -- 28 Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia -- 29 Prolymphocytic Leukemia -- 30 Hairy Cell Leukemia -- Part 6 Hodgkin Lymphoma -- 31 Classic Hodgkin Lymphoma -- 32 Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- 33 Hematopoietic Cell Transplantation and Cellular Therapy in Hodgkin Lymphoma -- Part 7 Non-Hodgkin's Lymphomas -- 34 Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas -- 35 Follicular Lymphoma -- 36 Mantle Cell Lymphoma -- 37 Marginal Zone Lymphoma -- 38 Hematopoietic Cell Transplantation and Cellular Therapy in Indolent Non-Hodgkin's Lymphomas -- 39 Diffuse Large B Cell Lymphoma -- 40 Hematopoietic Cell Transplantation and Cellular Therapy in Diffuse Large B Cell Lymphoma -- 41 Primary Mediastinal Large B Cell Lymphoma -- 42 Double-Hit and Double-Expressor Lymphomas -- 43 Transformed Lymphoma -- 44 Burkitt Lymphoma -- 45 Primary and Secondary CNS Lymphomas -- 46 HIV-Associated Lymphoma -- 47 Waldenström's Macroglobulinemia -- 48 Primary Cutaneous Lymphomas -- 49 Mycosis Fungoides and Sézary Syndrome -- 50 Peripheral T-Cell Lymphoma -- Part 8 Plasma Cell Neoplasms and Related Disorders -- 51 Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma -- 52 Risk Stratification Including Measurable Residual Disease in Multiple Myeloma -- 53 Newly Diagnosed Multiple Myeloma: Transplant Eligible -- 54 Newly Diagnosed Multiple Myeloma: Transplant Ineligible -- 55 Relapsed/Refractory Multiple Myeloma -- 56 Light-chain (AL) Amyloidosis -- 57 Bispecific T Cell Engager and Cell Based Immune Therapy in Multiple Myeloma -- Part 9 Special Issues in Neoplastic Hematology and Cellular Therapy -- 58 Treatment of Lymphomas During Pregnancy. 327 $a59 Complications and Management of CAR T Cell Therapy -- 60 Acute Graft-versus-Host Disease -- 61 Chronic Graft-versus-Host Disease -- Index -- EULA. 606 $aHematopoietic system$xCancer$vExaminations, questions, etc 606 $aHematological oncology$vExaminations, questions, etc 606 $aCellular therapy$vExaminations, questions, etc 615 0$aHematopoietic system$xCancer 615 0$aHematological oncology 615 0$aCellular therapy 676 $a616.99/418 702 $aAbutalib$b Syed A. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910829819503321 996 $aCancer consult$93932343 997 $aUNINA